+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults

Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults

Journal of the American Academy of Dermatology 80(6): 1544-1549

Paraneoplastic pemphigus (PNP) occurs more often in patients with hematologic malignancies (HMs) than in patients with solid cancer. Lung bronchiolitis obliterans (BO) is a severe complication of PNP. To determine the precise clinical and biologic features of HM-associated PNP and identify factors associated with mortality and survival. Systematic review of previously described cases of PNP associated with HMs. A total of 144 patients were included. The HMs were non-Hodgkin lymphoma (52.78%), chronic lymphocytic leukemia (22.92%), Castleman disease (18.60%), and other underlying hematologic malignancy (5.70%). The mortality rate was 57%, and most deaths occurred within the first year after the diagnosis of PNP. Multivariate analysis showed that (1) the presence of antienvoplakin antibodies and BO were significantly associated with death, and (2) a toxic epidermal necrolysis-like clinical pattern, bullous pemphigoid-like clinical pattern, and BO were significantly associated with decreased survival. Only case reports with sufficient mortality data were included. PNP associated with HM has a high mortality rate. The toxic epidermal necrolysis-like and BO-associated forms are independent survival factors in PNP associated with HMs.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066687718

Download citation: RISBibTeXText

PMID: 30981429

DOI: 10.1016/j.jaad.2018.03.043

Related references

Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies. Journal of Thrombosis and Haemostasis 8(8): 1702-1709, 2010

Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. Journal of Microbiology, Immunology, and Infection 39(2): 150-154, 2006

A pemphigus case with long term survival, implicating the spectrum between paraneoplastic pemphigus and pemphigus vulgaris. International Journal of Dermatology 36(12): 957-958, 1997

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transplant Infectious Disease 20(6): E12994, 2018

Function, Survival, and Care Utilization Among Older Adults With Hematologic Malignancies. Journal of the American Geriatrics Society 67(5): 889-897, 2019

Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan. Leukemia and Lymphoma 57(6): 1342-1348, 2016

Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. European Journal of Haematology 51(3): 156-160, 1993

Paraneoplastic glomerulopathies associated with hematologic malignancies. Saudi Journal of Kidney Diseases and Transplantation 29(2): 452-455, 2018

Mucocutaneous paraneoplastic manifestations of hematologic malignancies. American Journal of Medicine 99(2): 207-216, 1995

Mucocutaneous paraneoplastic syndromes associated with hematologic malignancies. Oncology 25(11): 1076-1083, 2011

Mucocutaneous paraneoplastic syndromes in hematologic malignancies. International Journal of Dermatology 45(1): 14-22, 2006

Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors. Haematologica 87(5): 528-534, 2002

Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies. Oncologist 6(Suppl. 5): 4-7, 2001

Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab. Journal of the European Academy of Dermatology and Venereology 32(2): E50-E52, 2018

Prognostic factors of outcome after unrelated cord blood transplant in adults with hematologic malignancies. Blood 96(11 Part 1): 587a, 2000